Contamination testing for beverage bottling
Linden Grain Medium for safe, reliable media fill simulations from EMD Millipore.
July 13, 2015 By Andrew Joseph
Cambridge, MA—EMD Millipore’s Linden Grain Medium for media fill simulations of low-acid aseptic beverage bottling and ice-crusher installations provides a high quality alternative to traditional powered media.
The granulated, ready-mixed Linden Grain Medium ensures excellent solubility, no component separation or clumping and minimized dust formation.
A key advantage of the granulated format compared to powdered formulations is that it limits the spread of media components that may be hazardous or lead to allergic reactions if inhaled.
This is especially important due to the quantity of media needed for media fill tests; powdered formats can generate a large amount of undesired dust in the aseptic production environment.
With a ready-mixed formulation, there is no need to source, buy, mix and quality control individual raw materials which can result in significant time and cost savings, especially when preparing large volumes.
The medium is available in 5kg and cost-saving 25kg sizes and meets the highest performance standards in production and QC as described in EN ISO 11133:2014.
Coca-Cola HBC AG, one of the world’s largest soft drinks bottlers, with operations in 28 countries, successfully applies Linden Grain Medium in its aseptic operations.
To complement the Linden Grain Medium, EMD Millipore offers a broad range of microbial air sampling and particle counting instruments and culture media in different formats for environmental monitoring.
For more information about granulated Linden Grain Medium click HERE.
About EMD Millipore
EMD Millipore is the U.S. Life Science subsidiary of Merck KGaA, Darmstadt, Germany. As part of the global Life Science business of Merck KGaA, Darmstadt, Germany, EMD Millipore offers a broad range of innovative, performance products, services and business relationships that enable customers’ success in research, development and production of biotech and pharmaceutical drug therapies. Through dedicated collaboration on new scientific and engineering insights, and as one of the top three R&D investors in the life science tools industry, the Life Science business of Merck KGaA, Darmstadt, Germany, serves as a strategic partner to customers and helps advance the promise of life science. Headquartered in Billerica, Massachusetts, the global business has around 10,000 employees, operations in 66 countries and 2014 revenues of €2.7 (~Cdn $3.78) billion.
For more information, please visit www.emdgroup.com.